Click for best price
Nerve Pain Treatment Market Size, Share 2024
The global Nerve Pain Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Tricyclic Antidepressants Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Nerve Pain Treatment include Pfizer Inc., Johnson & Johnson Services, Inc, Bristol-Myers Squibb Company, Sanofi S.A, Glaxosmithkline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd and Baxter International Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Nerve Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nerve Pain Treatment. This report contains market size and forecasts of Nerve Pain Treatment in global, including the following market information:
Global Nerve Pain Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Nerve Pain Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nerve Pain Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Nerve Pain Treatment Market Segment Percentages, by Type, 2023 (%)
Tricyclic Antidepressants
Opioids
Anticonvulsants
Others
Global Nerve Pain Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Nerve Pain Treatment Market Segment Percentages, by Application, 2023 (%)
Hospital
Retail Pharmacy
Others
Global Nerve Pain Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Nerve Pain Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nerve Pain Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Nerve Pain Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Johnson & Johnson Services, Inc
Bristol-Myers Squibb Company
Sanofi S.A
Glaxosmithkline plc
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd
Baxter International Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nerve Pain Treatment, market overview.
Chapter 2: Global Nerve Pain Treatment market size in revenue.
Chapter 3: Detailed analysis of Nerve Pain Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nerve Pain Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nerve Pain Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nerve Pain Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nerve Pain Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nerve Pain Treatment Overall Market Size
2.1 Global Nerve Pain Treatment Market Size: 2023 VS 2030
2.2 Global Nerve Pain Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nerve Pain Treatment Players in Global Market
3.2 Top Global Nerve Pain Treatment Companies Ranked by Revenue
3.3 Global Nerve Pain Treatment Revenue by Companies
3.4 Top 3 and Top 5 Nerve Pain Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Nerve Pain Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nerve Pain Treatment Players in Global Market
3.6.1 List of Global Tier 1 Nerve Pain Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Nerve Pain Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nerve Pain Treatment Market Size Markets, 2023 & 2030
4.1.2 Tricyclic Antidepressants
4.1.3 Opioids
4.1.4 Anticonvulsants
4.1.5 Others
4.2 By Type - Global Nerve Pain Treatment Revenue & Forecasts
4.2.1 By Type - Global Nerve Pain Treatment Revenue, 2019-2024
4.2.2 By Type - Global Nerve Pain Treatment Revenue, 2025-2030
4.2.3 By Type - Global Nerve Pain Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nerve Pain Treatment Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Nerve Pain Treatment Revenue & Forecasts
5.2.1 By Application - Global Nerve Pain Treatment Revenue, 2019-2024
5.2.2 By Application - Global Nerve Pain Treatment Revenue, 2025-2030
5.2.3 By Application - Global Nerve Pain Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Nerve Pain Treatment Market Size, 2023 & 2030
6.2 By Region - Global Nerve Pain Treatment Revenue & Forecasts
6.2.1 By Region - Global Nerve Pain Treatment Revenue, 2019-2024
6.2.2 By Region - Global Nerve Pain Treatment Revenue, 2025-2030
6.2.3 By Region - Global Nerve Pain Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Nerve Pain Treatment Revenue, 2019-2030
6.3.2 US Nerve Pain Treatment Market Size, 2019-2030
6.3.3 Canada Nerve Pain Treatment Market Size, 2019-2030
6.3.4 Mexico Nerve Pain Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Nerve Pain Treatment Revenue, 2019-2030
6.4.2 Germany Nerve Pain Treatment Market Size, 2019-2030
6.4.3 France Nerve Pain Treatment Market Size, 2019-2030
6.4.4 U.K. Nerve Pain Treatment Market Size, 2019-2030
6.4.5 Italy Nerve Pain Treatment Market Size, 2019-2030
6.4.6 Russia Nerve Pain Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Nerve Pain Treatment Market Size, 2019-2030
6.4.8 Benelux Nerve Pain Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Nerve Pain Treatment Revenue, 2019-2030
6.5.2 China Nerve Pain Treatment Market Size, 2019-2030
6.5.3 Japan Nerve Pain Treatment Market Size, 2019-2030
6.5.4 South Korea Nerve Pain Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Nerve Pain Treatment Market Size, 2019-2030
6.5.6 India Nerve Pain Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Nerve Pain Treatment Revenue, 2019-2030
6.6.2 Brazil Nerve Pain Treatment Market Size, 2019-2030
6.6.3 Argentina Nerve Pain Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nerve Pain Treatment Revenue, 2019-2030
6.7.2 Turkey Nerve Pain Treatment Market Size, 2019-2030
6.7.3 Israel Nerve Pain Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Nerve Pain Treatment Market Size, 2019-2030
6.7.5 UAE Nerve Pain Treatment Market Size, 2019-2030
7 Nerve Pain Treatment Companies Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Nerve Pain Treatment Major Product Offerings
7.1.4 Pfizer Inc. Nerve Pain Treatment Revenue in Global Market (2019-2024)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Johnson & Johnson Services, Inc
7.2.1 Johnson & Johnson Services, Inc Company Summary
7.2.2 Johnson & Johnson Services, Inc Business Overview
7.2.3 Johnson & Johnson Services, Inc Nerve Pain Treatment Major Product Offerings
7.2.4 Johnson & Johnson Services, Inc Nerve Pain Treatment Revenue in Global Market (2019-2024)
7.2.5 Johnson & Johnson Services, Inc Key News & Latest Developments
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Company Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company Nerve Pain Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Company Nerve Pain Treatment Revenue in Global Market (2019-2024)
7.3.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.4 Sanofi S.A
7.4.1 Sanofi S.A Company Summary
7.4.2 Sanofi S.A Business Overview
7.4.3 Sanofi S.A Nerve Pain Treatment Major Product Offerings
7.4.4 Sanofi S.A Nerve Pain Treatment Revenue in Global Market (2019-2024)
7.4.5 Sanofi S.A Key News & Latest Developments
7.5 Glaxosmithkline plc
7.5.1 Glaxosmithkline plc Company Summary
7.5.2 Glaxosmithkline plc Business Overview
7.5.3 Glaxosmithkline plc Nerve Pain Treatment Major Product Offerings
7.5.4 Glaxosmithkline plc Nerve Pain Treatment Revenue in Global Market (2019-2024)
7.5.5 Glaxosmithkline plc Key News & Latest Developments
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Company Summary
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company Nerve Pain Treatment Major Product Offerings
7.6.4 Eli Lilly and Company Nerve Pain Treatment Revenue in Global Market (2019-2024)
7.6.5 Eli Lilly and Company Key News & Latest Developments
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Company Summary
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Nerve Pain Treatment Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Ltd Nerve Pain Treatment Revenue in Global Market (2019-2024)
7.7.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.8 Baxter International Inc.
7.8.1 Baxter International Inc. Company Summary
7.8.2 Baxter International Inc. Business Overview
7.8.3 Baxter International Inc. Nerve Pain Treatment Major Product Offerings
7.8.4 Baxter International Inc. Nerve Pain Treatment Revenue in Global Market (2019-2024)
7.8.5 Baxter International Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nerve Pain Treatment Market Opportunities & Trends in Global Market
Table 2. Nerve Pain Treatment Market Drivers in Global Market
Table 3. Nerve Pain Treatment Market Restraints in Global Market
Table 4. Key Players of Nerve Pain Treatment in Global Market
Table 5. Top Nerve Pain Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Nerve Pain Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Nerve Pain Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Nerve Pain Treatment Product Type
Table 9. List of Global Tier 1 Nerve Pain Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nerve Pain Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Nerve Pain Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Nerve Pain Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Nerve Pain Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Nerve Pain Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Nerve Pain Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Nerve Pain Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Nerve Pain Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Nerve Pain Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Nerve Pain Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Nerve Pain Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Nerve Pain Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Nerve Pain Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Nerve Pain Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Nerve Pain Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Nerve Pain Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Nerve Pain Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Nerve Pain Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Nerve Pain Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Nerve Pain Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Pfizer Inc. Company Summary
Table 31. Pfizer Inc. Nerve Pain Treatment Product Offerings
Table 32. Pfizer Inc. Nerve Pain Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Pfizer Inc. Key News & Latest Developments
Table 34. Johnson & Johnson Services, Inc Company Summary
Table 35. Johnson & Johnson Services, Inc Nerve Pain Treatment Product Offerings
Table 36. Johnson & Johnson Services, Inc Nerve Pain Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Johnson & Johnson Services, Inc Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Company Summary
Table 39. Bristol-Myers Squibb Company Nerve Pain Treatment Product Offerings
Table 40. Bristol-Myers Squibb Company Nerve Pain Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Bristol-Myers Squibb Company Key News & Latest Developments
Table 42. Sanofi S.A Company Summary
Table 43. Sanofi S.A Nerve Pain Treatment Product Offerings
Table 44. Sanofi S.A Nerve Pain Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Sanofi S.A Key News & Latest Developments
Table 46. Glaxosmithkline plc Company Summary
Table 47. Glaxosmithkline plc Nerve Pain Treatment Product Offerings
Table 48. Glaxosmithkline plc Nerve Pain Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Glaxosmithkline plc Key News & Latest Developments
Table 50. Eli Lilly and Company Company Summary
Table 51. Eli Lilly and Company Nerve Pain Treatment Product Offerings
Table 52. Eli Lilly and Company Nerve Pain Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Eli Lilly and Company Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Summary
Table 55. Teva Pharmaceutical Industries Ltd Nerve Pain Treatment Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd Nerve Pain Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 58. Baxter International Inc. Company Summary
Table 59. Baxter International Inc. Nerve Pain Treatment Product Offerings
Table 60. Baxter International Inc. Nerve Pain Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Baxter International Inc. Key News & Latest Developments
List of Figures
Figure 1. Nerve Pain Treatment Segment by Type in 2023
Figure 2. Nerve Pain Treatment Segment by Application in 2023
Figure 3. Global Nerve Pain Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Nerve Pain Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Nerve Pain Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nerve Pain Treatment Revenue in 2023
Figure 8. By Type - Global Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Nerve Pain Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Nerve Pain Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 16. US Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 28. China Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Nerve Pain Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Nerve Pain Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Pfizer Inc. Nerve Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Johnson & Johnson Services, Inc Nerve Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bristol-Myers Squibb Company Nerve Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Sanofi S.A Nerve Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Glaxosmithkline plc Nerve Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Eli Lilly and Company Nerve Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Teva Pharmaceutical Industries Ltd Nerve Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Baxter International Inc. Nerve Pain Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
